Ivermectin had a cult-like following during the COVID-19 pandemic. Did science ever prove it was an effective treatment? The ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why ...

A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...

Atebimetinib is an investigational oral deep cyclic inhibitor that targets MEK in the MAPK pathway, which is activated in many solid tumors including pancreatic cancer. Its mechanism of action is ...

The latest results from the phase 1b/2 OrigAMI-1 study showed an overall response rate (ORR) of 51% and a median progression-free survival (PFS) of 9.2 months. The data were especially encouraging in ...

The number of cases of of scabies have soared in the UK, with the UK Health Security Agency reporting a significant spike in ...